Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
51.25
-1.25 (-2.38%)
Jan 21, 2026, 4:08 PM HKT
Nanjing Leads Biolabs Statistics
Total Valuation
HKG:9887 has a market cap or net worth of HKD 10.44 billion. The enterprise value is 10.28 billion.
| Market Cap | 10.44B |
| Enterprise Value | 10.28B |
Important Dates
The last earnings date was Friday, November 28, 2025.
| Earnings Date | Nov 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:9887 has 198.89 million shares outstanding.
| Current Share Class | 153.28M |
| Shares Outstanding | 198.89M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 15.32% |
| Owned by Institutions (%) | 45.04% |
| Float | 116.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 90.87 |
| P/TBV Ratio | 91.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -32.65 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.07, with a Debt / Equity ratio of 2.86.
| Current Ratio | 1.07 |
| Quick Ratio | 0.88 |
| Debt / Equity | 2.86 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -42.63 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -254.67% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -1.64M |
| Employee Count | 192 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 53.37 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.65 |
| Average Volume (20 Days) | 453,987 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -326.82M |
| Pretax Income | -314.72M |
| Net Income | -314.72M |
| EBITDA | -307.02M |
| EBIT | -326.82M |
| Earnings Per Share (EPS) | -2.04 |
Balance Sheet
The company has 494.97 million in cash and 328.25 million in debt, with a net cash position of 166.73 million or 0.84 per share.
| Cash & Cash Equivalents | 494.97M |
| Total Debt | 328.25M |
| Net Cash | 166.73M |
| Net Cash Per Share | 0.84 |
| Equity (Book Value) | 114.92M |
| Book Value Per Share | 0.73 |
| Working Capital | 40.30M |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
HKG:9887 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -3.01% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |